Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - October 6, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce the first paid demonstration trials of BVT's Clonostachys rosea CR-7 (CR-7) proprietary biological fungicide with two berry growers in Mexico. The trials will gather data on bee vectoring with CR-7 on common fungal diseases including Botrytis (gray mold).
Since submitting the registration dossier to Mexican regulatory authorities in April this year, BVT has been establishing strong relationships with Mexican growers. Currently, in addition to the two paid demonstration trials already planned, the team continues to work on securing more trials with farmers in Mexico for the upcoming growing season.
"Having these first two growers fund trials at this stage is a very positive development," said Ian Collinson, Sales Manager at BVT. "It means the value of BVT's natural precision agriculture system is being recognized early in the market development process in Mexico. Both growers have Botrytis fungal disease challenges and are excited to see how CR-7 can help them manage the disease."
The 4-month trials will take place on two berry farms in the state of Guanajuato that currently use commercial bees. They will start by late October, timed with berry bloom periods.
"The BVT system provides natural, precise, and continuous delivery of CR-7 to control Botrytisin berry crops, with the potential to increase yields up to 30%. Growers in the US have seen their ROI expand up to 20 times using the BVT system, and these new trials will help validate the technology in Mexico," continued Mr. Collinson. "Both growers are very keen to start the trials; having expressed how innovative, simple and elegant they find the BVT system. They are eager to be among the first to implement and evaluate a new biological fungicide not yet introduced in Mexico."
About Bee Vectoring Technologies International Inc.
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides - and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide and has US EPA registration of its Vectorite™ with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.
Additional information can be viewed at the Company's website www.beevt.com. To receive regular news updates from the Company, subscribe at www.beevt.com/newsletter.
Company Contact:
Ashish Malik, President & CEO
info@beevt.com